Skip to main content

Comparative study of 5-day cefcapene-pivoxil and 10-day amoxicillin or cefcapene-pivoxil for treatment of group A streptococcal pharyngitis in children

Abstract

In order to compare the bacteriological and clinical efficacy and safety of cefcapene-pivoxil (CFPN-PI) for 5 days, CFPN-PI for 10 days, and amoxicillin (AMPC) for 10 days for the treatment of pharyngitis due to group A β-hemolytic streptococcus (GAS) in children, a prospective multicenter randomized open-label comparative study was performed with 12 pediatric clinics in Asahikawa between June 2006 and February 2007. Two hundred and fifty children (age range 6 months to 12 years) with signs and symptoms of acute pharyngitis were enrolled. All had a positive throat culture for GAS and were fully evaluable. Eighty-two patients received CFPN-PI 9–10 mg/kg/day three times a day for 5 days, 88 received CFPN-PI three times a day for 10 days, and 80 received AMPC three times a day for 10 days. The CFPN-PI for 5 days regimen, the CFPN-PI for 10 days regimen, and the AMPC for 10 days regimen produced bacteriological eradication at the end of treatment in 93.8%, 96.2%, and 91.7% of the patients, respectively. The clinical cure rate observed at the end of therapy was 100% of the patients in the three groups. Relapse rates were 1.3% in CFPN-PI for 5 days, 4.0% in CFPN-PI for 10 days, and 2.9% in AMPC for 10 days. There were no significant differences in eradication rate, clinical cure rate, and relapse rate between the three treatment groups. The only adverse effects were infrequent diarrhea in all three groups, and a rash which occurred in 6 patients (8.0%) of the AMPC treatment group. Five days of treatment with CFPN-PI was as efficacious in bacteriological eradication and clinical response as 10 days of CFPN-PI or AMPC treatment.

This is a preview of subscription content, access via your institution.

References

  1. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96:758–764.

    PubMed  CAS  Google Scholar 

  2. American Academy of Pediatrics. 2006 American Academy of Pediatrics, Red Book: Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village: American Academy of Pediatrics; 2006.

  3. Kaplan EL, Johnson DR. Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001;108:1180–1186.

    PubMed  Article  CAS  Google Scholar 

  4. Casey JR, Pichichero ME. Metaanalysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics 2004;113:866–882.

    PubMed  Article  Google Scholar 

  5. Casey JR, Pichichero ME. Metaanalysis of short-course antibiotic treatment for group A streptococcal tonsillopharyngitis. Pediatr Infect Dis J 2005;24:909–917.

    PubMed  Article  Google Scholar 

  6. Totsuka K, Shimizu K, Konishi M, Yamamoto S. Metabolism of S-1108, a new oral cephem antibiotic, and metabolic profiles of its metabolites in humans. Antimicrob Agents Chemother 1992;36:757–761.

    PubMed  CAS  Google Scholar 

  7. Portier H, Chavanet P, Waldner-Combernoux A, Kisterman JP, Grey PC, Ichou F, et al. Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin. Scand J Infect Dis 1994;26:59–66.

    PubMed  Article  CAS  Google Scholar 

  8. Tack KJ, Henry DC, Gooch WM, Brink DN, Keyserling CH. Five-day cefdinir treatment for streptococcal pharyngitis. Antimicrob Agents Chemother 1998;42:1073–1075.

    PubMed  CAS  Google Scholar 

  9. Sela S, Barzilai A. Why do we fail with penicillin in the treatment of group A Streptococcus infections? Ann Med 1999;31:303–307.

    PubMed  CAS  Article  Google Scholar 

  10. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis 1984;6:601–607.

    PubMed  CAS  Google Scholar 

  11. Sanders CC, Nelson GE, Sanders WE Jr. Bacterial interference. IV. Epidemiological determinants of the antagonistic activity of the normal throat flora against group A streptococci. Infect Immun 1977;16:599–603.

    PubMed  CAS  Google Scholar 

  12. Yoshioka H, Fujita K, Maruyama S, Oka R. Changes in aerobic pharyngeal flora related to antibiotic use and the emergence of Gram-negative bacilli. Clin Pediatr 1982;21:460–462.

    Article  CAS  Google Scholar 

  13. Osterlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol 1995;115:685–688.

    PubMed  Article  CAS  Google Scholar 

  14. Dombek PE, Cue D, Sedgewick J, Lam H, Ruschkowski S, Finlay BB, et al. High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol 1999;31:859–870.

    PubMed  Article  CAS  Google Scholar 

  15. Shulman ST, Gerber MA. So what’s wrong with penicillin for strep throat? Pediatrics 2004;113:1816–1819.

    PubMed  Article  Google Scholar 

  16. Shulman ST. Acute streptococcal pharyngitis in pediatric medicine. Pediatr Drugs 2003;5(Suppl 1):13–23.

    Google Scholar 

  17. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis 2002;35:113–125.

    PubMed  Article  Google Scholar 

  18. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981;98:326–335.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Sakata.

About this article

Cite this article

Sakata, H. Comparative study of 5-day cefcapene-pivoxil and 10-day amoxicillin or cefcapene-pivoxil for treatment of group A streptococcal pharyngitis in children. J Infect Chemother 14, 208–212 (2008). https://doi.org/10.1007/s10156-008-0597-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-008-0597-0

Key words

  • Streptococcus pyogenes
  • Pharyngitis
  • Cefcapene-pivoxil
  • Amoxicillin